Abstract
Drug addiction and alcoholism are behavioural disorders characterized by a profound alteration of several brain circuits induced by chronic drug use. Their treatment is yet based on empiricism and today only few pharmacological strategies are fully effective to control both drug use and relapse. The present paper reviews the most updated pharmacotherapies able to contrast both alcoholism and drug addiction including the new patented drugs and the future therapeutic trends.
Keywords: Alcoholism, addiction, buprenorphine, methadone, suboxone®, naltrexone, gamma-hydroxybutyrrate, nociceptin peptide receptors, CB1 cannabinoid receptors, dopamine
Recent Patents on CNS Drug Discovery (Discontinued)
Title: New Frontiers in Alcoholism and Addiction Treatment
Volume: 5 Issue: 1
Author(s): Felice Nava, Andrea Vendramin, Ezio Manzato, Mauro Cibin and Alfio Lucchini
Affiliation:
Keywords: Alcoholism, addiction, buprenorphine, methadone, suboxone®, naltrexone, gamma-hydroxybutyrrate, nociceptin peptide receptors, CB1 cannabinoid receptors, dopamine
Abstract: Drug addiction and alcoholism are behavioural disorders characterized by a profound alteration of several brain circuits induced by chronic drug use. Their treatment is yet based on empiricism and today only few pharmacological strategies are fully effective to control both drug use and relapse. The present paper reviews the most updated pharmacotherapies able to contrast both alcoholism and drug addiction including the new patented drugs and the future therapeutic trends.
Export Options
About this article
Cite this article as:
Nava Felice, Vendramin Andrea, Manzato Ezio, Cibin Mauro and Lucchini Alfio, New Frontiers in Alcoholism and Addiction Treatment, Recent Patents on CNS Drug Discovery (Discontinued) 2010; 5 (1) . https://dx.doi.org/10.2174/157488910789753567
DOI https://dx.doi.org/10.2174/157488910789753567 |
Print ISSN 1574-8898 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3954 |
Related Articles
-
Serotonin Receptors of Type 6 (5-HT6): What can we Expect from them?
Current Medicinal Chemistry Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?
Current Cancer Drug Targets The Hypothalamic-Pituitary-Adrenal Axis: What can it Tell us About Stressors?
CNS & Neurological Disorders - Drug Targets Aqueous Extract of <i>Cola nitida</i> and <i>Garcinia kola</i> Synergistically Enhances Hippocampal-hypothalamic Glutamate and Na+ /K+ -ATPase Activity in Male Wistar Rats
Current Drug Discovery Technologies Novel Approaches to the Pharmacotherapy of Obesity
Current Pharmaceutical Design Inhaled Corticosteroids in Asthmatic Children: Are They as Safe in Infants and Preschoolers as in Older Children? A Review
Current Drug Safety Chemical Composition and Inhibitory Effects of Hypericum brasiliense and H. connatum on Prolyl Oligopeptidase and Acetylcholinesterase Activities
Medicinal Chemistry Association of Hypothyroidism with Body Mass Index, Systolic Blood Pressure and Proteinuria in Diabetic Patients: Does treated Hypothyroidism with Thyroxine Replacement Therapy Prevent Nephropathy/Chronic Renal Disease?
Current Diabetes Reviews Current Perspectives for the use of Gonane Progesteronergic Drugs in the Treatment of Central Hypoventilation Syndromes
Current Neuropharmacology Stroke in Women - Oral Contraception, Pregnancy, and Hormone Replacement Therapy
Current Vascular Pharmacology Urinary Steroids Measured by Modern Separation Techniques and Applied as Biomarkers in Stress Studies
Current Pharmaceutical Analysis Changes in Histaminergic System in Neuropsychiatric Disorders and the Potential Treatment Consequences
Current Neuropharmacology Naturally Occurring and Related Synthetic Cannabinoids and their Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) Effects of Mindfulness on Diabetes Mellitus: Rationale and Overview
Current Diabetes Reviews Redox Processes in Neurodegenerative Disease Involving Reactive Oxygen Species
Current Neuropharmacology Pituitary Dysfunction as a Cause of Cardiovascular Disease
Current Pharmaceutical Design Aspartimide Modified Galanin Analogue Antagonizes Galanin Action on Insulin Secretion
Protein & Peptide Letters Emerging Trends in Endometriosis Treatment - Review
Current Women`s Health Reviews Ghrelin and Growth Hormone Secretagogues, Physiological and Pharmacological Aspect
Current Drug Discovery Technologies Neuropeptides and Other Chemical Mediators, and the Role of Anti-inflammatory Drugs in Primary Headaches
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry